Last reviewed · How we verify
NCT05701137
Effectiveness of an EMDR Intervention for Perinatal Loss
NA trial testing EMDR-RTE in Pregnancy Loss in 40 participants. Completed in 23 March 2025.
30 November 2024
Quick facts
| Lead sponsor | Hospital Clinic of Barcelona |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 17 April 2023 |
| Primary completion | 30 November 2024 |
| Estimated completion | 23 March 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- EMDR-RTE
- TAU — full drug profile →
Conditions studied
- Pregnancy Loss — all drugs for Pregnancy Loss →
- PTSD — all drugs for PTSD →
Sponsor
Hospital Clinic of Barcelona
Who can join
18 and older, female only, with Pregnancy Loss or PTSD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators objectives is to assess the effectiveness of Eye Movement Desensitization and Reprocessing - recent traumatic episode (EMDR-RTE) as a preventive intervention for Posttraumatic Stress Disorder (PTSD) symptoms after perinatal loss. The hypothesis is that EMDR-RTE treatment may prevent post-traumatic and depressive symptoms in women who suffered perinatal loss.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of an eye movement desensitization and reprocessing intervention for the prevention of post- traumatic symptoms in perinatal loss: a randomized pilot controlled trial.
Sureda-Caldentey B, Garcia-Gibert C, Martínez A, Giménez Y, et al · · 2025 · PMID 40551815 · DOI 10.3389/fpsyt.2025.1593306
Verify or expand the search:
- PubMed search for NCT05701137
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pregnancy Loss
Currently open trials in the same condition.
- NCT05127252 — Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive · recruiting
- NCT05418140 — Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment · active not recruiting
- NCT06963528 — Gestational Diabetes Monitoring and Management · active not recruiting
- NCT03775954 — Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise · recruiting
Other Hospital Clinic of Barcelona trials
Trials by the same sponsor.
- NCT07509814 — Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery · NA · not yet recruiting
- NCT07469358 — iCBT for Adolescents Obsessive-compulsive Dissorder · NA · active not recruiting
- NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation · NA · recruiting
- NCT07237867 — Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar T · NA · recruiting
- NCT07163936 — Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Diseas · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05701137 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Clinic of Barcelona
- Last refreshed: 4 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05701137.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing